Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

835 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, Nagatomo I, Takeda Y, Kida H, Goya S, Yoshida M, Kumagai T, Tachibana I, Yokota S, Kawase I. Kohmo S, et al. Among authors: otani y. Cancer Res. 2010 Oct 15;70(20):8025-35. doi: 10.1158/0008-5472.CAN-10-0996. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940407
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.
Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, Takahashi R, Miyake K, Higashiguchi M, Morimura O, Ihara S, Tsujino K, Hirata H, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A. Minami T, et al. Among authors: otani y. Sci Rep. 2013;3:2669. doi: 10.1038/srep02669. Sci Rep. 2013. PMID: 24036898 Free PMC article.
Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism.
Kijima T, Shimizu T, Nonen S, Furukawa M, Otani Y, Minami T, Takahashi R, Hirata H, Nagatomo I, Takeda Y, Kida H, Goya S, Fujio Y, Azuma J, Tachibana I, Kawase I. Kijima T, et al. Among authors: otani y. J Clin Oncol. 2011 Jul 1;29(19):e588-90. doi: 10.1200/JCO.2010.34.3368. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502555 No abstract available.
Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.
Iwasaki T, Takeda Y, Maruyama K, Yokosaki Y, Tsujino K, Tetsumoto S, Kuhara H, Nakanishi K, Otani Y, Jin Y, Kohmo S, Hirata H, Takahashi R, Suzuki M, Inoue K, Nagatomo I, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I, Kumanogoh A. Iwasaki T, et al. Among authors: otani y. J Biol Chem. 2013 Jan 25;288(4):2118-31. doi: 10.1074/jbc.M112.424291. Epub 2012 Dec 5. J Biol Chem. 2013. PMID: 23223239 Free PMC article.
Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.
Takimoto T, Kijima T, Otani Y, Nonen S, Namba Y, Mori M, Yokota S, Minami S, Komuta K, Uchida J, Imamura F, Furukawa M, Tsuruta N, Fujio Y, Azuma J, Tachibana I, Kumanogoh A. Takimoto T, et al. Among authors: otani y. Clin Lung Cancer. 2013 Sep;14(5):502-7. doi: 10.1016/j.cllc.2013.03.003. Epub 2013 May 9. Clin Lung Cancer. 2013. PMID: 23664723
Favorable responses to tocilizumab in two patients with cancer-related cachexia.
Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, Otani Y, Inoue K, Kuhara H, Shimada K, Nagatomo I, Takeda Y, Goya S, Yoshizaki K, Kawase I, Tachibana I, Kishimoto T, Kumanogoh A. Hirata H, et al. Among authors: otani y. J Pain Symptom Manage. 2013 Aug;46(2):e9-e13. doi: 10.1016/j.jpainsymman.2013.01.009. Epub 2013 Apr 17. J Pain Symptom Manage. 2013. PMID: 23602326 Free article. No abstract available.
835 results